Skip to content

Intensive Care Program for Youth With Diabetes

Intensive Care Program for Youth With Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00961974
Enrollment
154
Registered
2009-08-19
Start date
2002-04-30
Completion date
2005-06-30
Last updated
2021-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

type 1 diabetes, hemoglobin A1c, family, involvement, responsibility, conflict, quality of life, children

Brief summary

The purpose of this study was to determine the ability of a family-focused, office-based intervention to improve medical and behavioral outcomes for children and adolescents with type 1 diabetes.

Interventions

BEHAVIORALCare Ambassador Intervention

Care Ambassador provides additional monthly outreach (by phone or e-mail) to families between clinic visits.

BEHAVIORALPsychoeducational Intervention

A psychoeducational intervention module is reviewed with the family by the Care Ambassador at each clinic visit. The intervention focuses on incorporating intensive therapy into the daily routine of the child through positive family support for blood glucose monitoring and healthy eating. The intervention modules review positive family communication, realistic expectations, ways to avoid perfectionism and maintain family involvement, prevention of hypoglycemia, avoidance of diabetes-specific family conflict, and approaches to reducing diabetes burnout.

Sponsors

Charles H. Hood Foundation
CollaboratorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Joslin Diabetes Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Age 8-16 years * Type 1 diabetes diagnosed by standard American Diabetes Association criteria * Type 1 diabetes duration of at least 6 months * Residence in northeastern U.S. * Established clinic patient * Fluency in English or Spanish

Exclusion criteria

* Major psychiatric disorder (e.g., major depression, severe eating disorder, mental retardation) * Unstable living environment (e.g., Department of Social Services or Department of Youth Services involvement)

Design outcomes

Primary

MeasureTime frame
Glycemic control, assessed by hemoglobin A1cEvery 3 months

Secondary

MeasureTime frame
Psychosocial factors (diabetes-specific family conflict, responsibility-sharing for diabetes management tasks, quality of life, affect regarding blood glucose monitoring, disordered eating behaviors)Annually
Weight, assessed by z-BMI (age- and gender-adjusted body mass index)Every 3 months
Frequency of hospitalizations, emergency department visits, and episodes of severe hypoglycemiaEvery 3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026